Scilex Holding (SCLX) Operating Leases (2021 - 2026)
Scilex Holding (SCLX) posted quarterly Operating Leases of $12.7 million for Q1 2026, up 855.99% year-over-year from $1.3 million in Q1 2025, and down 3.54% on a QoQ basis from $13.2 million in Q4 2025.
Scilex Holding (SCLX) Operating Leases (2021 - 2026) Analysis & Trends
Scilex Holding (SCLX) has reported Operating Leases for 6 consecutive years, with $12.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Leases rose 855.99% year-over-year to $12.7 million; the TTM figure through Mar 2026 stood at $12.7 million (up 855.99% YoY), while the FY2025 annual figure was $13.2 million, up 763.49% from the prior year.
- Operating Leases came in at $12.7 million for Q1 2026 at Scilex Holding, down from $13.2 million in the prior quarter.
- The five-year high for Operating Leases was $13.2 million in Q4 2025, with the low at $461000.0 in Q1 2023.
- Average Operating Leases over 5 years is $3.2 million, with a median of $1.8 million recorded in 2024.
- Across the five-year window, Operating Leases slumped 46.44% in 2025 and soared 855.99% in 2026, its largest moves.
- Year by year, Operating Leases stood at $665000.0 in 2022, then jumped by 236.39% to $2.2 million in 2023, then tumbled by 31.92% to $1.5 million in 2024, then jumped by 763.49% to $13.2 million in 2025, then retreated by 3.54% to $12.7 million in 2026.
- According to Business Quant data, Operating Leases over the past three periods registered $12.7 million, $13.2 million, and $918000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - |
| 10 | Scilex Holding | 54.30 Mn | -95.62 Mn | 4.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.69 Mn |
| Dec 31, 2025 | 13.15 Mn |
| Sep 30, 2025 | 918,000.00 |
| Jun 30, 2025 | 1.13 Mn |
| Mar 31, 2025 | 1.33 Mn |
| Dec 31, 2024 | 1.52 Mn |
| Sep 30, 2024 | 1.71 Mn |
| Jun 30, 2024 | 1.89 Mn |
| Mar 31, 2024 | 2.07 Mn |
| Dec 31, 2023 | 2.24 Mn |
| Sep 30, 2023 | 2.40 Mn |
| Jun 30, 2023 | 2.59 Mn |
| Mar 31, 2023 | 461,000.00 |
| Dec 31, 2022 | 665,000.00 |
| Dec 31, 2021 | 1.15 Mn |